Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis

Published:2021-06-28 Issue:7 Volume:73 Page:983-989
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Wiese Michael D.¹^ORCID,Hopkins Ashley M.²^ORCID,King Catherine¹^ORCID,Wechalekar Mihir D.³^ORCID,Lee Anita⁴^ORCID,Spargo Llewellyn⁵^ORCID,Metcalf Robert⁵,McWilliams Leah⁵,Hill Catherine⁶^ORCID,Cleland Leslie G.⁵,Proudman Susanna M.⁴^ORCID

Affiliation:

1. University of South Australia Adelaide South Australia Australia

2. Flinders University of South Australia Bedford Park South Australia Australia

3. Flinders University of South Australia and Flinders Medical Centre Bedford Park South Australia Australia

4. Royal Adelaide Hospital and The University of Adelaide Adelaide Medical School Adelaide South Australia Australia

5. Royal Adelaide Hospital Adelaide South Australia Australia

6. Royal Adelaide Hospital and The University of Adelaide Adelaide, and The Queen Elizabeth Hospital Woodville South Australia Australia

Funder

Arthritis Australia

Publisher

Wiley

Subject